Diabetes

By Dave Muoio June 20, 2018
Digital chronic disease management company Omada Health announced today the launch of new programs designed to support individuals with Type 2 diabetes and hypertension. Accompanying these are a set of new features for the enterprise and health plan platform focused on medication adherence and remote monitoring, all of which comprise what a representative from the company described as “the...
DreaMed Diabetes tool gets FDA approval
By Dave Muoio June 18, 2018
The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes. “This is an innovation that can improve people’s lives and the FDA decision confirms what we believe is an important step in making a more meaningful connection between the healthcare provider and their type 1 diabetes patients...
By Laura Lovett June 11, 2018
Glooko announced the launch of the new version of its Glooko Web Application platform this morning. The site aims to give users more resources with a streamlined navigation tool and an assortment of diabetes analytics, charts, and graphs.  “We are truly excited to supply PWDs and clinicians with the most comprehensive set of reports and analytics on diabetes data available today,” Sam Wyndbrant,...
By Laura Lovett May 17, 2018
Yesterday, startup LifePlus exited stealth mode to reveal what it claims to be the first noninvasive continuous blood glucose monitoring multi-sensor wearable, called LifeLeaf. Although details are scare on exactly how the technology works, the company said the product is being tested in five clinical trials around the world.  “We have been in stealth mode and today we are thrilled to announce...
By Dave Muoio May 10, 2018
Of the hundreds of diabetes self-management apps currently available, very few have been evaluated with health outcome-focused studies, according to a recent report by the Agency for Healthcare Research and Quality (AHRQ). Among this subset, even fewer have been shown to actually help diabetes patients significantly improve their HbA1c levels. Prior research has shown that 16 percent of the 318,...
By Dave Muoio April 23, 2018
Researchers from the University of California San Diego have developed a low-cost, single-use tattoo-like wearable that measures the user’s glucose levels. According to a release from the institution, this noninvasive technology will be at the center of a newly announced pilot clinical trial designed to test the accuracy and acceptability of the tattoos. “Drawing blood is uncomfortable. No one...
By Dave Muoio April 12, 2018
The FDA has granted diagnostics company IDx’s De Novo request to market its AI-based software system for the autonomous detection of diabetic retinopathy in adults who have diabetes, called IDx-DR. This decision represents the first AI-based diagnostic system authorized by the FDA for commercialization in the US that can provide a screening decision without the need for clinician interpretation,...
By Dave Muoio March 29, 2018
San Francisco-based microsensor textile company Siren has announced the first product using its proprietary Neurofabric material. The Siren Diabetic Sock and Foot Monitoring System and its accompanying app monitor wearers’ foot temperature as an early warning sign of inflammation and, subsequently, diabetic foot ulcers. The company, which was founded in 2015, also announced that it has raised $3....
By Laura Lovett March 28, 2018
Yesterday Dexcom got the nod from the FDA to market their Dexcom G6, an integrated continuous glucose monitoring system (iCGM), making it the first interoperable CGM to get the designation.  “We are a company of firsts, almost everything that has been done in our industry has been done by us first,” Dexcom CEO Kevin Sayer told MobiHealthNews, citing that Dexcom was the first company to have a...
By Laura Lovett March 8, 2018
A recent Johns Hopkins study found that prediabetic patients who used the interactive mobile coaching program Sweetch lost weight and increased physical activity.   The study, published in JMIR, found that participant lost a mean 3.5 pounds and significantly improved weekly physical activity over the course of the three-month trial. Participants also saw a decrease in HBa1C or glycated hemoglobin...

Editor's Pick